WebMD: Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2 Diabetes The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections. Awiqli: FDA Approves First and Only Once-Weekly Long-Acting Basal Insulin for Adults With Type 2 Diabetes The American Journal of Managed Care: $35 Insulin Cap Cut Medicare Spending but Failed to Attract New Users Capping Medicare beneficiaries’ monthly insulin out-of-pocket costs at $35 was associated with steep reductions in spending and modest but meaningful improvements in glycemic control —yet did little ... $35 Insulin Cap Cut Medicare Spending but Failed to Attract New Users Sketchpad: Free online drawing application for all ages.
Create digital artwork to share online and export to popular image formats JPEG, PNG, SVG, and PDF. Sketch Mobile is a drawing tool that takes advantage of the new capabilities presented in modern mobile browsers; including multi-touch, the accelerometer, and the gyroscope; providing a fun & novel environment to express yourself in colorful ways! Sketch Mobile was commissioned by Google as part of the Mobile Chrome Experiments released at Google I/O 2012. Sketch Mobile utilizes multi-touch ...
